Denali Therapeutics Inc. (DNLI) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Denali Therapeutics Inc., Ultragenyx Pharmaceutical Inc..Total Return (%)
Denali Therapeutics Inc. (DNLI)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Denali Therapeutics Inc.
DNLI
Ultragenyx Pharmaceutical Inc.
RARE
| Metric | Denali Therapeutics Inc. (DNLI) | Ultragenyx Pharmaceutical Inc. (RARE) |
|---|---|---|
| Current Price | $14.52 | $30.36 |
| Change | 0.57 (4.09%) | 1.28 (4.40%) |
| Market Cap | $2.12B | $2.93B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -5.28 | -5.94 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $33.33 | $57.99 |
| 52-Week Low | $10.57 | $25.81 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.92 | $-5.72 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| DNLI | -6.02% | -37.68% | -49.35% | -60.64% | -32.31% | -32.31% |
| RARE | -5.21% | -29.44% | -46.27% | -64.58% | -69.33% | -68.48% |